BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12722409)

  • 1. [Hormonal abnormalities in women with breast cysts].
    Wypych K; Kuźlik R; Wypych P
    Ginekol Pol; 2002 Nov; 73(11):1117-25. PubMed ID: 12722409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The concentrations of prolactin and estrogens in women with fibrocystic changes in the breast].
    Sieja K; Stanosz S
    Ginekol Pol; 2002 Jul; 73(7):594-9. PubMed ID: 12375569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levels of estrogen, progesterone, prolactin and sex hormone-binding globulin in the blood and breast cysts].
    Vlaisavljević V; Adamcic M
    Jugosl Ginekol Perinatol; 1986; 26(5-6):97-9. PubMed ID: 3657280
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-endorphin, steroids, and prolactin. Immunoassay in breast cysts and blood.
    Schön HJ; Schurz B; Wenzl R; Knogler W; Kubista E
    Arch Pathol Lab Med; 1993 Mar; 117(3):248-53. PubMed ID: 8442670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mastopathy and breast cancer: is there a typical hormone profile?].
    Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin secretion in benign breast diseases.
    Sitruk-Ware R; Clair F; Sterkers N; Ulmann A; Mauvais-Jarvis P
    Gynecol Endocrinol; 1987 Jun; 1(2):195-200. PubMed ID: 3140581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum oestradiol-17 beta and prolactin concentrations during the luteal phase in women with benign breast disease.
    Walsh PV; McDicken IW; Bulbrook RD; Moore JW; Taylor WH; George WD
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1345-51. PubMed ID: 6542005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THE ROLE OF E2/P RATIO IN THE ETIOLOGY OF FIBROCYSTIC BREAST DISEASE, MASTALGIA AND MASTODYNIA.
    Brkić M; Vujović S; Ivović M; Tančić Gajić M; Marina L; Franić Ivanišević M; Franić D
    Acta Clin Croat; 2018 Dec; 57(4):756-761. PubMed ID: 31168213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G; Govindarajulu P; Ramalingam V
    Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
    Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prolactin in serum and anamnestic data of women with cystic disease of the breast (author's transl)].
    Bischoff J; Rebhan EM; Prestele H; Becker H
    Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):65-71. PubMed ID: 7353778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins.
    Rose DP; Boyar AP; Cohen C; Strong LE
    J Natl Cancer Inst; 1987 Apr; 78(4):623-6. PubMed ID: 3104646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of danazol treatment of women with fibrocystic disease of breast].
    Baranowska B; Stopińska-Głuszak U
    Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):771-3. PubMed ID: 2701752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of selected hormonal parameters in patients with mastopathy in postmenopausal period].
    Mizia-Stec K; Zych F; Widala E
    Ginekol Pol; 1998 Feb; 69(2):56-61. PubMed ID: 9591381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum prolactin levels in women with gross cystic breast disease.
    Vizoso F; Allende MT; García-Muñiz JL; Alexandre E; Fueyo A; Ruibal A
    Int J Biol Markers; 1992; 7(4):225-9. PubMed ID: 1491178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prolactin and oestradiol levels in women with cyclical mastalgia.
    Watt-Boolsen S; Andersen AN; Blichert-Toft M
    Horm Metab Res; 1981 Dec; 13(12):700-2. PubMed ID: 7319468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "luteal breast": hormonal and sonographic investigation of benign breast disease in patients with cyclic mastalgia.
    Ayers JW; Gidwani GP
    Fertil Steril; 1983 Dec; 40(6):779-84. PubMed ID: 6653797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrinology of benign breast disease in relation to the severity of radiological dysplasia.
    Junkermann H; Klinga K; Weber E; von Fournier D
    Horm Res; 1989; 32 Suppl 1():10-4. PubMed ID: 2613196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endocrine markers in benign breast diseases].
    Thalabard JC; Sitruk-Ware R; Kuttenn F; Mauvais-Jarvis P
    Zentralbl Gynakol; 1986; 108(6):354-8. PubMed ID: 3716674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.